Skip to main content
Have a personal or library account? Click to login
Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells Cover

Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells

Open Access
|Nov 2009

References

  1. Sersa G, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy of tumours.2006; 40: 163-74.
  2. Teissie J, Escoffre JM, Rols MP, Golzio M. Time dependence of electric field effects on cell membranes. A review for a critical selection of pulse duration for therapeutical applications.2008; 42: 196-206.
  3. Cemazar M, Sersa G, Miklavcic D. Electrochemotherapy with cisplatin in the treatment of tumour cells resistant to cisplatin.1998; 18: 4463-6.
  4. Orlowski S, Belehradek J Jr, Paoletti, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs.1988; 37: 4727-33.
  5. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro.2000; 11: 201-8.
  6. Cemazar M, Miklavcic D, Mir LM, Belehradek J Jr, Bonnay M, Fourcault D, et al. Electrochemotherapy of tumours resistant to cisplatin: a study in a murine tumour model.2001; 37: 1166-72.
  7. Sersa G. The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses.2006; 4: 52-9.
  8. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study.2006; 4: 3-13.
  9. Kuriyama S, Matsumoto M, Mitoro A, Tsujinoue H, Nakatani T, Fukui H, et al. Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model.2000; 45: 1568-77.
  10. Kuriyama S, Tsujinoue H, Toyokawa Y, Mitoro A, Nakatani T, Yoshiji H, et al. A potential approach for electrochemotherapy against colorectal carcinoma using a clinically available alternating current system with bipolar snare in a mouse model.2001; 36: 297-302.
  11. Cemazar M, Miklavcic D, Sersa G. Intrinsic sensitivity of tumour cells to bleomycin as an indicator of tumour response to electrochemotherapy.1998; 45: 328-33.
  12. Kranjc S, Cemazar M, Grosel A, Pipan Z, Sersa G. Effect of electroporation on radiosensitization with cisplatin in two cell lines with different chemo- and radiosensitivity.2003; 37: 101-7.
  13. Kambe M, Arita D, Kikuchi H, Funato T, Tezuka F, Gamo M, et al. Enhancement of the efficacy of anticancer drugs with electroporation: successful electrochemotherapy against gastric cancer cell linesand.1997; 2: 111-7.
  14. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours.2008; 34: 232-40.
  15. Fuertes MA, Castilla J, Alonso C, Perez JM. Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.2003; 10: 257-66.
  16. Cepeda V, Fuertes M, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical mechanisms of cisplatin cytotoxicity.2007; 7: 3-18.
  17. Tounekti O, Kenani A, Foray N, Orlowski S, Mir LM. The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway.2001; 84: 1272-9.
  18. Chen J, Stubbe J. Bleomycins: towards better therapeutics.2005; 5: 102-12.
  19. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance.2003; 22: 7265-79.
  20. Tounekti O, Pron G, Belehradek J, Mir LM. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized.1993; 53: 5462-9.
  21. Gonzales VM, Fuertes MA, Alonso C, Perez JM. Is cisplatin-induced cell death always produced by apoptosis?2001; 59: 657-63.
  22. Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs.2005; 4: 307-20.
  23. Mekid H, Tounekti O, Spatz A, Cemazar M, El Kebir FZ, Mir LM.evolution of tumour cells after the generation of double-strand DNA breaks.2003; 88: 1763-71.
  24. Vakifahmetoglu H, Olsson M, Tamm C, Heidari N, Orrenius S, Zhivotovsky B. DNA damage induces two distinct modes of cell death in ovarian carcinomas.2008; 15: 555-66.
  25. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level.2008; 9: 231-41.
  26. Sadadcharam M, Soden DM, O'Sullivan GC. Electrochemotherapy: An emerging cancer treatment.2008; 24: 263-73.
DOI: https://doi.org/10.2478/v10019-009-0037-5 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 264 - 273
Published on: Nov 20, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Vesna Todorovic, Gregor Sersa, Karel Flisar, Maja Cemazar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.